Johnson & Johnson42

جزئیات گزارش

Position on Clinical Trial Data Transparency - Johnson & Johnson

At Johnson & Johnson Innovative Medicine (J&J IM), we believe transparency of clinical trial data
advances science and medicine and is in the best interest of the patients who use our pharmaceutical
products and the providers who prescribe them. As such, we support the overall principles of greater
clinical trial data transparency, including registration and disclosure of clinical trial results in external
registries, publication of results in peer-reviewed journals, sharing of clinical...
نوع گزارش
Report
زبان
انگلیسی
سال
2024
فرمت
217.97 MB - PDF
استانداردهای گزارش: GRI ISSB UN SDG
دانلود گزارش